Ionis Pharmaceuticals (IONS) Change in Cash (2009 - 2026)

Ionis Pharmaceuticals' Change in Cash history runs 18 years deep, the most recent figure standing at -$198.9 million for Q1 2026.

• On a quarterly basis, Change in Cash fell 999.29% year-over-year to -$198.9 million in Q1 2026; TTM through Mar 2026 was -$90.8 million, a 7.22% decrease from a year earlier, with the FY2025 full-year figure at $130.2 million, up 182.82% from the prior year.
• Change in Cash declined to -$198.9 million in Q1 2026 per IONS's latest filing, from $33.9 million in the prior quarter.
• Across five years, Change in Cash topped out at $115.8 million in Q2 2023 and bottomed at -$326.7 million in Q1 2022.
• The 5-year median for Change in Cash is -$20.6 million (2022), against an average of -$40.9 million.
• Across the five-year window, Change in Cash sank 2080.95% in 2022 and soared 662.05% in 2023, its largest moves.
• Year by year, Change in Cash stood at -$38.5 million in 2022, then jumped by 222.55% to $47.2 million in 2023, then plunged by 296.01% to -$92.5 million in 2024, then surged by 136.66% to $33.9 million in 2025, then plunged by 686.34% to -$198.9 million in 2026.
• Per Business Quant, the three latest IONS Change in Cash figures stand at -$198.9 million (Q1 2026), $33.9 million (Q4 2025), and $41.0 million (Q3 2025).